RARE
Ultragenyx Pharmaceutical Inc
Price:  
29.48 
USD
Volume:  
2,063,693.00
United States | Biotechnology
Valuation
Overview
Financials
Forecast
Compare
Historical Price
SolvencyDividends
Transactions
People

RARE Fair Value

-193.79 %
Upside

What is the fair value of RARE?

As of 2025-09-17, the Fair Value of Ultragenyx Pharmaceutical Inc (RARE) is -27.65 USD. This value is based on the Peter Lynch's Fair Value formula. With the current market price of 29.48 USD, the upside of Ultragenyx Pharmaceutical Inc is -193.79%.

Is RARE a good investment?

With the market price of 29.48 USD and our fair value calculation, Ultragenyx Pharmaceutical Inc (RARE) is not a good investment. Investing in RARE stocks now will result in a potential loss of 193.79%.

Note: valuation result may not be accurate due to the company's negative EPS.

29.48 USD
Stock Price
-27.65 USD
Fair Price
FAIR VALUE CALCULATION

RARE Fair Value

Peter Lynch's formula is:

RARE Fair Value
= Earnings Growth Rate x TTM EPS
RARE Fair Value
= 5.00 x -5.53
RARE Fair Value
= -27.65

The earnings growth rate we use in the formula is the average growth rate of net income/earnings over the last 5 years. If the average growth rate is smaller than 5%, we set it to 5%. If it is larger than 25%, we set it to 25%. If the TTM EPS is negative, Peter Lynch Fair Value's result can be unreliable.

Historical Earnings
2020-12-31 2021-12-31 2022-12-31 2023-12-31 2024-12-31 5Y Avg
Net income -186.60 -454.00 -707.40 -606.64 -569.18 -504.76
YoY growth 53.66% -143.30% -55.81% 14.24% 6.17% -25.01%

RARE Fair Value - Key Data

Market Cap (mil) 2,840.99
P/E
Forward P/E
EPS -5.53
Avg earnings growth rate -25.01%
TTM earnings -532.93